Judge Blocks DOJ Transgender Patient Data
Analysis based on 6 articles · First reported May 14, 2026 · Last updated May 14, 2026
The court ruling blocking the United States — United States Department of Justice's subpoenas could reduce legal and reputational risks for healthcare providers like United States — Rhode Island and NYU Langone Health involved in gender-affirming care. This event highlights ongoing regulatory scrutiny in the pharmaceutical and healthcare sectors, particularly concerning off-label drug promotion and patient data privacy, which may lead to increased compliance costs or shifts in investment for companies operating in these areas.
A federal judge, Mary McElroy, blocked the United States — United States Department of Justice's sweeping demands for confidential transgender patient information from United States — Rhode Island, the state's largest provider of gender-affirming care to minors. The United States — United States Department of Justice had sought birth dates, Social Security numbers, and addresses of patients, along with details on adverse side effects and assessments for prescribing puberty blockers or hormone therapy, citing an investigation into potential fraud or unlawful off-label promotion of drugs. Judge Mary McElroy criticized the United States — United States Department of Justice's conduct, stating it had proven "unworthy of this trust." This decision is part of a broader legal battle, with other federal courts quashing or limiting similar subpoenas sent to over 20 doctors and hospitals. Separately, NYU Langone Health also received a grand jury subpoena from federal prosecutors in Texas for similar information, indicating a wider federal investigation. The United States — United States Department of Justice has stated it will appeal the Rhode Island court's decision.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard